News
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced detailed results from two Phase 3 trials in adults with recurring severe chronic rhinosinusitis with nasal polyps (CRSwNP ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback
